DelveInsight’s Graves’ Disease Market Report offers a comprehensive understanding of Graves’ Disease, historical and forecasted epidemiology, and Graves’ Disease market patterns in the 7MM (United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan).
Some of the Important Findings from the Graves’ Disease Market Report
- According to Wemeau et al. (2018), 73.3 percent of 1,572 hyperthyroid patients in France had Graves’ Disease (primary or recurrence), with 85 percent of them being female.
- According to Minamitani et al. (2017), Graves’ Disease is responsible for the majority of childhood hyperthyroidism cases. Pediatric patients account for fewer than 5% of all Graves’ Disease patients, with a prevalence of 0.02 percent.
- In the United Kingdom, autoimmune hyperthyroidism (Graves’ Disease) is the most prevalent type, accounting for 60 to 80 percent of cases, according to the National Institute for Health and Care Excellence (NICE) (2019).
- Iscalimab (Novartis) and Secukinumab (Novartis) are the pipeline therapies in the Graves’ Disease Market.
- Novartis is among the key pharmaceutical companies which are currently active in the Graves’ Disease Market.
- The rise in Graves’ Disease market size is a direct result of the increase in 7MM cases. The Graves’ Disease therapeutic market is expected to expand due to improved disease understanding and advancements in therapeutic management.
Request Sample @ Graves’ Disease Market Insights
The Graves’ Disease market report covers existing clinical trends, new drugs, Graves’ Disease market share of individual therapies, and current and forecasted Graves’ Disease market size from 2018 to 2030 segmented by seven major markets.
Graves’ Disease is a form of hyperthyroidism that affects many people. Thyroid-stimulating immunoglobulins are antibodies produced by the immune system in this autoimmune disorder. They then bind to healthy thyroid cells, triggering an overproduction of thyroid hormone in the body.
Thyroid hormones have an effect on the nervous system, brain growth, body temperature, and other vital aspects. It induces weight loss, anxiety, jitteriness, irritability, depression, and mental or physical exhaustion if left untreated. Other risks include vision issues, heart problems, skin problems, and so on.
Graves’ Disease Epidemiology Segmentation
- Graves’ Disease Total Prevalence
- Graves’ Disease Gender-Specific Cases
- Graves’ Disease Age-Specific Cases
Know more about epidemiology @ Graves’ Disease Causes, Treatment and Epidemiology
Graves’ Disease Treatment Landscape
For people with Graves’ Disease, there are three treatment options: medication, radioiodine therapy, and thyroid surgery. In the United States, radioiodine therapy remains the most popular treatment for Graves’ Disease, although physicians are starting to use medicine more often than in the past.
The best care for the patient is determined by the patient’s age, pregnancy, and the involvement of other medical conditions.
Owing to a rise in the number of cases, as well as a better understanding of the disease and new therapies such as Iscalimab (Novartis) and Secukinumab (Novartis), the Graves’ Disease market size is expected to expand during the forecast period (2021-2030).
Graves’ Disease Pipeline Therapies and Key Companies
- Iscalimab: Novartis
- Secukinumab: Novartis
Get more insights about emerging drugs @ Graves’ Disease Emerging Therapies and Major Players
Table of Contents
| 1. | Key Insights |
| 2. | Graves’ Disease : Market Overview at a Glance |
| 3. | Executive Summary |
| 4. | Organizations |
| 5. | Graves’ Disease Patient Journey |
| 6. | Disease Overview: Graves’ Disease |
| 7. | Graves’ Disease Epidemiology and Patient Population |
| 8. | Graves’ Disease Case studies |
| 9. | Graves’ Disease Emerging Therapies |
| 10. | Graves’ Disease : Market Outlook |
| 11. | Graves’ Disease Market Drivers |
| 12. | Graves’ DiseaseMarket Barriers |
| 13. | Graves’ Disease Market access and Reimbursement |
| 14. | SWOT Analysis |
| 15. | Graves’ Disease Unmet Needs |
| 16. | KOL Views |
| 17. | Appendix |
| 18. | Disclaimer |
| 19. | About DelveInsight |
Know more about report offerings @ Graves’ Disease Market Outlook
Related Reports
DelveInsight’s “Graves Ophthalmopathy – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well as the Graves Ophthalmopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Graves Orbitopathy – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves Orbitopathy , historical and forecasted epidemiology as well as the Graves Orbitopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get comprehensive historical and forecast analysis of High Grade Glioma Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Genentech, Merck, Orbus Therapeutics, Bayer, MedImmune, Aivita Biomedical, among others.
Granulomatosis With Polyangiitis Market
Get comprehensive historical and forecast analysis of Granulomatosis With Polyangiitis Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Genentech, Biogen Idec, GlaxoSmithKline, Bristol-Myers Squibb, among others.
Low-Grade Upper Tract Urothelial Cancer Market
DelveInsight’s “Low-Grade Upper Tract Urothelial Cancer (LG UTUC) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Low-Grade Upper Tract Urothelial Cancer (LG UTUC) , historical and forecasted epidemiology as well as the Low-Grade Upper Tract Urothelial Cancer (LG UTUC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get comprehensive historical and forecast analysis of Dravet Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Biocodex, GW Pharmaceuticals, Zogenix, Ovid Therapeutics, PTC Therapeutics, among others.
DelveInsight’s “Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alzheimer’s Disease, historical and forecasted epidemiology as well as the Alzheimer’s disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Parkinson’s Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Parkinson’s Disease, historical and forecasted epidemiology as well as the Parkinson’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Adult-Onset Still’s Disease Market
Get comprehensive historical and forecast analysis of Adult-Onset Still’s Disease Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Novartis, Swedish Orphan Biovitrum, Roche, Cerecor, AB2 Bio Ltd, among others.
Get comprehensive historical and forecast analysis of Celiac Disease Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Takeda/Cour Pharmaceuticals, Precigen ActoBio, Falk Pharma and Zedira, among others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187
Connect With Us at:
Contact Information:
Sandeep Joshi info@delveinsight.com +1(919)321-6187
Tags:
, Reportedtimes, Menafn, IPS, PR-Wirein, Extended Distribution, iCN Internal Distribution, Research Newswire, English
Contact Information:
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187
The post The Anticipated Introduction of Emerging Therapies by Pharma Giant Novartis is expected to boost the market for Graves’ Disease appeared first on Financial Market Brief.
